Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2009-07-22Phase II Trial of High-dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2009-07-21Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b.SWiss Atorvastatin and Interferon-Beta 1b Trial In Multiple Sclerosis.
-
CLINICAL_TRIALS study record update · 2009-06-23EARLY IFNb-1a (Rebif) and Atorvastatin (Lipitor) Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2009-06-22An Open-Label, Multicenter Extension Study to Evaluate the Safety and Tolerability of Natalizumab in Subjects With Multiple Sclerosis Who Have Completed Studies C-1801, C-1802, or C-1803
-
CLINICAL_TRIALS study record update · 2009-06-11Proposal to Create a Flagship Neurology and Palliative Care Service for South London
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2009-06-10A Multicenter, Open-Label Immunogenicity and Safety Study of a Serum-Free Pre-Formulated Solution of AVONEX (Interferon Beta-1a) Administered Intramuscularly to Patients With Relapsing/Remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2009-06-08An Open-Label Safety Extension Study of AVONEX® (Interferon Beta-1a) Treatment in Subjects Who Completed Biogen Studies C95-812, C96-823, or C97-830
-
CLINICAL_TRIALS study record update · 2009-06-08An Open-Label, Multicenter Study to Determine Subject Satisfaction in Using the Single-Use Autoinjector With a Pre-Filled Liquid AVONEX® Syringe in Multiple Sclerosis Subjects
-
CLINICAL_TRIALS study record update · 2009-06-04A Randomized, Single-Blind, Crossover Study in Healthy Volunteers to Demonstrate the Bioequivalence of AVONEX® (Interferon Beta-1a) Solutions for Injection Produced by a Serum-Containing Manufacturing Process and by a Serum-Free Manufacturing Process
-
CLINICAL_TRIALS study record update · 2009-06-04A Pilot Multi-Center, Open-Label, Assessor Blinded, Prospective Profiling Study in MS Subjects Treated With AVONEX®, MS Subjects Naïve to Treatment, and Healthy Control Subjects
-
CLINICAL_TRIALS study record update · 2009-05-04An Integrated Motor Imagery Program in Rehabilitation - a RCT
-
CLINICAL_TRIALS study record update · 2009-03-12ClinicalTrials.gov study NCT00006060
-
CLINICAL_TRIALS study record update · 2009-02-19Long Term Clinical Efficacy and Safety of Novel Sublingual Tizanidine HCl (12 mg) for the Treatment of Spasticity in Patients With Multiple Sclerosis - Open Label Extension Study
-
CLINICAL_TRIALS study record update · 2009-01-05Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for Multiple Sclerosis.
-
CLINICAL_TRIALS study record update · 2008-10-17Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case Study
-
CLINICAL_TRIALS study record update · 2008-09-09ClinicalTrials.gov study NCT00004744
-
CLINICAL_TRIALS study record update · 2008-08-12Multiple Sclerosis and Muscle Function - Effects of Heavy Progressive Resistance Training
-
CLINICAL_TRIALS study record update · 2008-08-05A Phase II Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2008-06-11Constraint-Induced Movement Therapy Trial for Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2008-06-04Auditory Function in Patients With and Without Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2008-05-28A Randomized, Double-Blind, Placebo-Controlled, Dose-Titration Study to Assess the Safety, Tolerability, and Efficacy of C105 in Persons With Multiple Sclerosis With Cognitive Impairment
-
CLINICAL_TRIALS study record update · 2008-05-19A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone on Quality of Life as Measured by the Multiple Sclerosis Quality of Life Inventory (MSQLI54)
-
CLINICAL_TRIALS study record update · 2008-04-07A Phase I Trial of Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2008-03-28A Phase I/II Dose-Escalation Trial of Vitamin D3 With Calcium Supplementation in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2008-03-21A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of NBI-5788 in Patients With Relapsing Multiple Sclerosis